AstraZeneca PLC is 42.1x more valuable than Protagonist Therapeutics, Inc by market capitalization ($286.27 B vs $6.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTGX | AZN |
|---|---|---|
| Market cap | $6.80 B | $286.27 B |
| US-listed rank | #1171 | #45 |
| Net income (latest FY) | -$130.15M | - |
| SEC filings | 668 | 1,004 |
AstraZeneca PLC is 42.1x more valuable than Protagonist Therapeutics, Inc by market capitalization ($286.27 B vs $6.80 B).
Full pages: Protagonist Therapeutics, Inc and AstraZeneca PLC, or browse the full rankings.